Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 10520.142 | 0.9491 | 0.9674 | 3.1766 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 10520.142 | 0.9026 | 0.9365 | 3.1766 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 10520.142 | 0.9179 | 0.9468 | 3.1766 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 10520.142 | 0.0012 | -0.7591 | 3.1766 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 11057.154 | 0.9521 | 0.9747 | 3.8498 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 11057.154 | 1.0458 | 1.0234 | 3.8498 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 11057.154 | 0.9839 | 0.9916 | 3.8498 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 11057.154 | 0.9127 | 0.9531 | 3.8498 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 11057.154 | 0.9933 | 0.9965 | 3.8498 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 11057.154 | 0.9303 | 0.9628 | 3.8498 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 11057.154 | 1.0119 | 1.0062 | 3.8498 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 11057.154 | 0.5673 | 0.7262 | 3.8498 | |
SUM159PT | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 11057.154 | 0.0032 | -0.5505 | 3.8498 | |
SUM185PE | TNBC | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 12269.154 | 0.6759 | 0.3518 | 0.9999 | |
SUM185PE | TNBC | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 12269.154 | 0.9909 | 0.9818 | 0.9999 | |
SUM185PE | TNBC | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 12269.154 | 0.6791 | 0.3581 | 0.9999 | |
SUM185PE | TNBC | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 12269.154 | 0.9279 | 0.8558 | 0.9999 | |
SUM185PE | TNBC | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 12269.154 | 0.6981 | 0.3962 | 0.9999 | |
SUM185PE | TNBC | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 12269.154 | 0.9292 | 0.8583 | 0.9999 | |
SUM185PE | TNBC | Luminal | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 12269.154 | 0.6666 | 0.3332 | 0.9999 | |
SUM185PE | TNBC | Luminal | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 12269.154 | 0.9168 | 0.8335 | 0.9999 | |
SUM185PE | TNBC | Luminal | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 12269.154 | 0.5472 | 0.0944 | 0.9999 | |
SUM225CWN | HER2amp | Basal A | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 10579.142 | 0.9492 | 0.9025 | 1.0435 | |
SUM225CWN | HER2amp | Basal A | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 10579.142 | 0.9659 | 0.9346 | 1.0435 | |
SUM225CWN | HER2amp | Basal A | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 10579.142 | 0.9774 | 0.9566 | 1.0435 |